retatrutide: ESC 2024: Retatrutide improves lipid and cardiovascular risk profile in Phase II trial Retatrutide Delivers Significant Hemoglobin A1C
Description
CagriSema: Two Molecules, Complementary Mechanisms CagriSema combines two existing molecules in a fixed-dose injection
Legal challenges to the compounding restrictions have failed, with courts supporting the FDA interpretation that once a drug is no longer in shortage, the compounding exemptions no longer apply
The latest data also shows that most people stop taking GLP-1s within 12 months and experience significant side effects throughout treatment
GLP-1Rs are also expressed in platelets
Why the Day Before Matters The day before your injection is when many people can eat a little more normally
One of the most talked-about is Evolv GLP-1, an oral supplement marketed as a "biomimetic" way to activate the body's natural GLP-1 pathways without injections
